Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
about
A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding riskProthrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trialAn acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.Risks factors for highly unstable response to oral anticoagulation: a case-control study.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study.Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVALPerioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy.A model-based algorithm for the monitoring of long-term anticoagulation therapy.Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.Development of a clinical prediction model for an international normalised ratio ≥ 4·5 in hospitalised patients using vitamin K antagonists.VKORC1 inhibitors binds VKORC1 dimer
P2860
Q24817078-32580807-FBB1-42B7-864A-374FAA066369Q28265484-27A8AE56-21EF-41AD-A839-DA319DA087F9Q30558676-5ED38ACB-362A-4637-8AC8-DB1E4999F978Q33986110-25AE4D29-80DB-4E3C-ADC6-821C3DFBE8A2Q34252907-D98D1BA4-770A-4C89-9C3D-E6D0E68036E2Q34750575-23D0017A-B572-4CBC-B29E-3F8D0E5D2D48Q35099559-481575A2-42ED-4D2C-B484-51577DCBF78AQ35752584-1489756E-399F-4F58-857F-90F4086F66A5Q38364982-3C3D0C7E-CAE4-43A0-96C6-8CBEF0262AE4Q38584212-70C5019A-3490-4834-8DAA-D6BF147CE474Q39817828-47E727E9-78AD-43A4-AD3B-61D7454BD4E1Q46470678-57FDE937-E040-45EC-9BBE-1BAD71975CE4Q47649476-26048DA3-6994-4200-ABCD-6746F2D377EFQ53243301-9D19FA4D-10A0-42F0-876C-CA714F1E298EQ54959926-8DB90074-AA94-4B36-A77B-515504F54470Q56860028-429AA135-240E-4A46-80DB-0D2BE84797A3
P2860
Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Therapeutic quality control of ...... the long-acting phenprocoumon.
@en
Therapeutic quality control of ...... the long-acting phenprocoumon.
@nl
type
label
Therapeutic quality control of ...... the long-acting phenprocoumon.
@en
Therapeutic quality control of ...... the long-acting phenprocoumon.
@nl
prefLabel
Therapeutic quality control of ...... the long-acting phenprocoumon.
@en
Therapeutic quality control of ...... the long-acting phenprocoumon.
@nl
P2093
P2860
P1476
Therapeutic quality control of ...... the long-acting phenprocoumon
@en
P2093
Felix J M van der Meer
Frits R Rosendaal
Henk J Adriaansen
Stephan D Fihn
P2860
P304
P356
10.1046/J.1365-2141.2002.03493.X
P407
P577
2002-06-01T00:00:00Z